SLE and Serum Complement: Causative, Concomitant or Coincidental?

    September 2017 in “ The Open Rheumatology Journal ”
    Vaneet Kaur Sandhu, Michele Quan
    Studysummary This review discusses the role of complement activation in SLE and suggests that while monitoring C3 and C4 remains important, increased levels of cell-bound complement activation products may better indicate disease activity.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on openrheumatologyjournal.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Derivation And Validation Of The Systemic Lupus International Collaborating Clinics Classification Criteria For Systemic Lupus Erythematosus Arthritis & Rheumatism · 2012